SCHEMBL4640464

SCHEMBL4640464

CCCCC(OC(=O)c1ccc(Br)cc1C(=O)O)C(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
POLB P06746 1/20 0.43
AKR1C2 P52895 2/20 0.38
AKR1C1 Q04828 2/20 0.38
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
THRB P10828 1/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37
ATM Q13315 1/20 0.37
CTSK P43235 4/20 0.36
KDM4E B2RXH2 2/20 0.36
GLA P06280 1/20 0.36
MEN1 O00255 1/20 0.36
RECQL P46063 1/20 0.36
KMT2A Q03164 1/20 0.36
CA2 P00918 1/20 0.35
CYP3A4 P08684 1/20 0.35
SORT1 Q99523 2/20 0.35
MYC P01106 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4640461 0.94 ALDH1A1 (0.41) ALDH1A1POLBTSHRMAPK1THRB
SCHEMBL4639939 0.87 KDM4E (0.40) ALDH1A1POLBAKR1C2AKR1C1HPGD
SCHEMBL4640111 0.86 ALDH1A1 (0.44) ALDH1A1TSHRMAPK1CTSKCA2
SCHEMBL4640014 0.86 ALDH1A1 (0.44) ALDH1A1TSHRMAPK1HPGDCTSK
SCHEMBL4643107 0.86 ALDH1A1 (0.40) ALDH1A1POLBTSHRMAPK1THRB
SCHEMBL4640730 0.85 ALDH1A1 (0.43) ALDH1A1TSHRMAPK1CTSKKDM4E
SCHEMBL4641193 0.85 ALDH1A1 (0.43) ALDH1A1TSHRMAPK1CTSKKDM4E
SCHEMBL4640866 0.85 ALDH1A1 (0.43) ALDH1A1POLBTSHRMAPK1CTSK
SCHEMBL4639860 0.84 ALDH1A1 (0.47) ALDH1A1POLBAKR1C2AKR1C1TSHR
SCHEMBL4641266 0.83 ALDH1A1 (0.42) ALDH1A1TSHRMAPK1HPGDCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1188739-B1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO LTD (JP) 2008-08-13 EP disclosed
US-6670497-B2 Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst TOHO TITANIUM CO., LTD. (JP) 2003-12-30 US disclosed
US-20030036594-A1 Phthalic diester derivatives and electron donors TOHO TITANIUM CO., LTD. (JP) 2003-02-20 US disclosed
EP-1188739-A1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO., LTD. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036594-A1 Phthalic diester derivatives and electron donors HPD, ETFA, PPOX ALDH1A1 725/4885POLB 598/4885AKR1C2 1103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.